Cas:440102-50-1 6-[(2-amino-2-methyl-propyl)amino]pyridine-3-carboxamide manufacturer & supplier

Chemical Name:6-[(2-amino-2-methyl-propyl)amino]pyridine-3-carboxamide

CAS.NO:440102-50-1

Synonyms:6-[(2-amino-2-methyl-propyl)amino]pyridine-3-carboxamide

Molecular Formula:C₁₀H₁₆N₄O

Molecular Weight:208.26000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:425.2ºC at 760 mmHg

Density:1.196g/cm3

Index of Refraction:1.609

PSA:95.02000

Exact Mass:208.13200

LogP:1.98720

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 6-[(2-amino-2-methyl-propyl)amino]pyridine-3-carboxamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-[(2-amino-2-methyl-propyl)amino]pyridine-3-carboxamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-[(2-amino-2-methyl-propyl)amino]pyridine-3-carboxamide Use and application,6-[(2-amino-2-methyl-propyl)amino]pyridine-3-carboxamide technical grade,usp/ep/jp grade.

Related News: The company-backed investigation was based on interviews with more than 100 people, the May 20 memo to Lilly employees said. However, the memo did not respond to all concerns employees raised in their April complaint, which Reuters reviewed. 6-[(2-amino-2-methyl-propyl)amino]pyridine-3-carboxamide manufacturer Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS). 6-[(2-amino-2-methyl-propyl)amino]pyridine-3-carboxamide supplier It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion. 6-[(2-amino-2-methyl-propyl)amino]pyridine-3-carboxamide vendor APIs are generally manufactured through a variety of processes that include. 6-[(2-amino-2-methyl-propyl)amino]pyridine-3-carboxamide factory The company-backed investigation was based on interviews with more than 100 people, the May 20 memo to Lilly employees said. However, the memo did not respond to all concerns employees raised in their April complaint, which Reuters reviewed.